<code id='1E7F54A38D'></code><style id='1E7F54A38D'></style>
    • <acronym id='1E7F54A38D'></acronym>
      <center id='1E7F54A38D'><center id='1E7F54A38D'><tfoot id='1E7F54A38D'></tfoot></center><abbr id='1E7F54A38D'><dir id='1E7F54A38D'><tfoot id='1E7F54A38D'></tfoot><noframes id='1E7F54A38D'>

    • <optgroup id='1E7F54A38D'><strike id='1E7F54A38D'><sup id='1E7F54A38D'></sup></strike><code id='1E7F54A38D'></code></optgroup>
        1. <b id='1E7F54A38D'><label id='1E7F54A38D'><select id='1E7F54A38D'><dt id='1E7F54A38D'><span id='1E7F54A38D'></span></dt></select></label></b><u id='1E7F54A38D'></u>
          <i id='1E7F54A38D'><strike id='1E7F54A38D'><tt id='1E7F54A38D'><pre id='1E7F54A38D'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:3817
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Cheap, fast test for Zika and dengue could cost just $1
          Cheap, fast test for Zika and dengue could cost just $1

          NikolasAlbarranandJoseGomez-MarquezAnewblood testcancheaplyandquicklydistinguishbetweenthemosquito-b

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Pfizer is about to make a big push in cancer. Will investors listen?

          PfizerCEOAlbertBourlaGiannisPapanikos/APPfizerhasabigproblem.Thedruggianthopesthatnewdrugstotreatcan